Internal Medicine · Santa Rosa, CA
NPI
1871600031
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
401 Bicentennial Way, 240 Mob-W
Santa Rosa, CA, 95403
Phone (707) 571-3621
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$467K
796 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Zhen Zhou Feng prescribed most often to Medicare patients was Pantoprazole Sodium, with 199 prescriptions and refills. In total Zhen Zhou Feng wrote 796 Medicare prescriptions that cost $467K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Pantoprazole Sodium Generic | 199 | 630 | 100 | $2,814 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 134 | 134 | 133 | $3,048 |
| Mesalamine Generic | 41 | 125 | 15 | $21K |
| Xifaxan Rifaximin | 38 | 38 | 11 | $117K |
| Zenpep Lipase/Protease/Amylase | 33 | 104 | 16 | $55K |
| Azathioprine Generic | 30 | 99 | Under 11 | $1,354 |
| Balsalazide Disodium Generic | 26 | 86 | 11 | $7,080 |
| Cholestyramine Cholestyramine (With Sugar) | 25 | 32 | Under 11 | $2,041 |
| Omeprazole Generic | 24 | 75 | 14 | $275 |
| Budesonide Dr Budesonide | 20 | 51 | 12 | $1,798 |
| Ursodiol Generic | 15 | 41 | Under 11 | $3,134 |
| Lubiprostone Generic | 15 | 31 | Under 11 | $1,979 |
| Spironolactone Generic | 14 | 47 | Under 11 | $679 |
| Famotidine Generic | 14 | 38 | Under 11 | $158 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 14 | 14 | Under 11 | $325 |
Brand drugs: 150 claims; generic drugs: 646 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Zhen Zhou Feng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.